CVE-2013-10014

oktora24 2moons sql injection

Description

A vulnerability classified as critical has been found in oktora24 2moons. Affected is an unknown function. The manipulation leads to sql injection. The patch is identified as 1b09cf7672eb85b5b0c8a4de321f7a4ad87b09a7. It is recommended to apply a patch to fix this issue. VDB-218898 is the identifier assigned to this vulnerability.

Category

5.5
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.04%
Third-Party Advisory github.com Third-Party Advisory vuldb.com Third-Party Advisory vuldb.com
Affected: oktora24 2moons
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.218898 third party advisory vdb entry technical description
https://vuldb.com/?ctiid.218898 signature third party advisory permissions required
https://github.com/oktora24/2moons/commit/1b09cf7672eb85b5b0c8a4de321f7a4ad87b09a7 third party advisory patch

Frequently Asked Questions

What is the severity of CVE-2013-10014?
CVE-2013-10014 has been scored as a medium severity vulnerability.
How to fix CVE-2013-10014?
To fix CVE-2013-10014, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2013-10014 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2013-10014 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2013-10014?
CVE-2013-10014 affects oktora24 2moons.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.